Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Dokuz Eylül Üniversitesi-Hematology (Site 2304)

Izmir, 35340, TürkiyeNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Diffuse large B-cell lymphoma

Closed trials

Completed
A Study to Evaluate Zilovertamab Vedotin (MK-2140) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-004)
NCT05144841· Phase 2· Merck Sharp & Dohme LLC· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – Dokuz Eylül Üniversitesi-Hematology (Site 2304): trial site – Frontlight Research